Results 101 to 110 of about 6,976 (207)

Fact sheet for Molnupiravir. Hmong

, 2021
Title from PDF caption (viewed on January 4, 2022)."OHA4029C12292021 HMONG"--Running footer.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Fact sheet for Molnupiravir. Korean

, 2021
Title from PDF caption (viewed on January 4, 2022)."OHA4029C12292021 KOREAN"--Running footer.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Fact sheet for Molnupiravir. Somali

, 2021
Title from PDF caption (viewed on January 4, 2022)."OHA4029C12292021 SOMALI"--Running footer.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Molnupiravir inhibits Bourbon virus infection and disease-associated pathology in mice

Journal of Virology
Bourbon virus (BRBV) is an emerging tick-borne virus that can cause severe and fatal disease in humans. BRBV is vectored via the Amblyomma americanum tick, which is widely distributed throughout the central, eastern, and southern United States ...
Gayan Bamunuarachchi, Fang R. Zhao, Traci L. Bricker, Kuljeet Seehra, Andrew Karp, Michael S. Diamond, Adrianus C. M. Boon   +6 more
doaj   +1 more source

Expedient Synthesis of Antiviral Drug Molnupiravir from D-Ribose and Cytosine [PDF]

Molnupiravir, an approved antiviral drug for treating SARS-CoV-2-infected patients, presents a critical need for a concise and sustainable synthesis from readily available raw materials due to its potential high demand. Herein, we report a cost-effective
Jayashree, Rajput, Srinivas, Hotha, Saptashwa , Chakraborty, Yogesh, Sutar, Kameshwar, Prasad   +4 more
core   +2 more sources

Fact sheet for Molnupiravir. Russian

, 2021
Title from PDF caption (viewed on January 4, 2022)."OHA4029C12292021 RUSSIAN"--Running footer.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program. It is for informational purposes and may

core  

GS-441524 and molnupiravir are similarly effective for the treatment of cats with feline infectious peritonitis

Frontiers in Veterinary Science
Although not registered for feline infectious peritonitis (FIP) in Japan, nucleoside analogs have shown efficacy and we have been offering them to owners of cats with FIP at our clinic since January 2020. The aim of this study was to investigate outcomes
Okihiro Sase, Tomoko Iwami, Takeru Sasaki, Tadashi Sano   +3 more
doaj   +1 more source

Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis

Journal of Microbiology, Immunology and Infection
Background: The majority of available data on molnupiravir come from an unvaccinated COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence from recent randomized controlled trials (RCTs) as well as observational studies ...
Huzaifa Ahmad Cheema, Saleha Abdul Rab, Momina Butt, Uzair Jafar, Abia Shahid, Aqeeb Ur Rehman, Ka Yiu Lee, Syeda Sahra, Ranjit Sah   +8 more
doaj   +1 more source

Fact sheet for Molnupiravir. Marshallese

, 2021
Title from PDF caption (viewed on January 4, 2022)."OHA4029C12292021 MARSHALLESE"--Running footer.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program. It is for informational purposes and

core  

Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study

Italian Journal of Medicine
COVID-19 represents a threat for frailty patients. This study compares molnupiravir and nirmatrelvir for fragile COVID- 19 patients' efficacy, safety, and cost.
Filomena Pietrantonio, Francesco Rosiello, Matteo Ruggeri, Maria Sofia Cattaruzza, Antonio Vinci, Margherita Lordi, Enrica Cipriano   +6 more
doaj   +1 more source